It gives me great pleasure to announce that Signature Partners earned a shared savings payment of $931,291 for 2016. This payment is based on a total cost of care for our attributed patient population that increased at a trend of 2.1% for 2016, compared to the “market trend” (non-Signature Partners) of 8.9%. In a nutshell, this means that PCPs in Signature Partners controlled cost significantly better than non-Signature Partners. Thanks to all of you for your hard work!
Based on our board-approved shared savings allocation model for 2016, gain share payments are being made to practices with 20 or more attributed Innovation Health members, and are based entirely on attribution, with no variance based on quality. In 2017 and beyond, quality performance will be factored in as well.
For 2017, we will have 3 “must pass” quality measures to access any shared savings, which you should be aware of. These include: 1) Hemoglobin A1c testing completed in 89% or more of our diabetic patients, 2) 300 or more “high risk” patients enrolled in care plans, and 3) completing a coding audit of 3 charts per provider. If we don’t pass all three of these, then we will not earn any shared savings bonus. In addition, because of the criteria for clinical integration and the need to collect quality metrics, gain share payments will be limited to those practices which are either on an EMR, or will be on an EMR by the end of 2017.
What can you do to maximize your bonus in 2017?
It is important to realize that although we kept cost down in 2016, we have significant opportunities to keep them down even further in 2017 and 2018. We must all do our part to practice high quality, cost efficient medicine, which will be rewarded by additional value-based payments. This payment for 2016 should be considered only a small taste of what is possible.
Thank you again for your participation in Signature Partners, and congratulations for earning this payment for 2016. The entire team looks forward to working even harder with you to achieve the triple aim for our patients.
Matthew Poffenroth, MD, MBA
CEO/CMO, Signature Partners
Copyright 2017 Signature Partners -